Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 15, 2022, the Board of Directors (the "Board") of Vicapsys Life Sciences, Inc. (the "Company") appointed Federico Pier as Chief Executive Officer of the Company. Mr. Pier has served as Interim Chief Executive Officer since August 2020, and as Executive Chairman of the Board since May 2019.

Mr. Pier, age 54, was appointed as the Executive Chairman of the Board in May 2019, and has served as the Company's Interim Chief Executive Officer since August 2020. He is the Managing Director of YPH, LLC, a multifamily office investing in life sciences, energy, and technology. Mr. Pier has more than 25 years of experience in reverse mergers, structured finance, convertible debt and straight equity. He previously as a Senior Director at Oppenheimer & Co. and Managing Director at Bear Stearns. He holds a Bachelors' degree from the University of North Texas and an MBA from the Graduate School of Management at the University of Dallas.




Item 8.01. Other Events.

On April 12, 2022, the Company issued a press release regarding Mr. Pier's appointment as Chief Executive Officer, a copy of which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description

99.1            Press release of the registrant issued on April 12, 2022.
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

© Edgar Online, source Glimpses